Blood sample quality

Abstract Several lines of evidence now confirm that the vast majority of errors in laboratory medicine occur in the extra-analytical phases of the total testing processing, especially in the preanalytical phase. Most importantly, the collection of unsuitable specimens for testing (either due to inappropriate volume or quality) is by far the most frequent source of all laboratory errors, thus calling for urgent strategies for improving blood sample quality and managing data potentially generated measuring unsuitable specimens. A comprehensive overview of scientific literature leads us to conclude that hemolyzed samples are the most frequent cause of specimen non-conformity in clinical laboratories (40–70%), followed by insufficient or inappropriate sample volume (10–20%), biological samples collected in the wrong container (5–15%) and undue clotting (5–10%). Less frequent causes of impaired sample quality include contamination by infusion fluids (i.e. most often saline or glucose solutions), cross-contamination of blood tubes additives, inappropriate sample storage conditions or repeated freezing-thawing cycles. Therefore, this article is aimed to summarize the current evidence about the most frequent types of unsuitable blood samples, along with tentative recommendations on how to prevent or manage these preanalytical non-conformities.

[1]  A. Šimundić,et al.  Call for more transparency in manufacturers declarations on serum indices: On behalf of the Working Group for Preanalytical Phase (WG-PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). , 2018, Clinica chimica acta; international journal of clinical chemistry.

[2]  Giuseppe Lippi,et al.  Are we getting better at the preanalytical phase or just better at measuring it , 2018 .

[3]  G. Lippi,et al.  Laboratory hemostasis: from biology to the bench , 2018, Clinical chemistry and laboratory medicine.

[4]  G. Lippi,et al.  Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity? , 2018, Blood transfusion = Trasfusione del sangue.

[5]  Mario Plebani,et al.  A Six-Sigma approach for comparing diagnostic errors in healthcare-where does laboratory medicine stand? , 2018, Annals of translational medicine.

[6]  A. Šimundić,et al.  Practical recommendations for managing hemolyzed samples in clinical chemistry testing , 2018, Clinical chemistry and laboratory medicine.

[7]  A. Šimundić,et al.  Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers , 2018, Clinical chemistry and laboratory medicine.

[8]  A. Leichtle,et al.  Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes , 2017, Biochemia medica.

[9]  A. Šimundić,et al.  The EFLM strategy for harmonization of the preanalytical phase , 2017, Clinical chemistry and laboratory medicine.

[10]  A. Šimundić,et al.  Preanalytical variation and preexamination processes , 2018 .

[11]  M. Plebani,et al.  Laboratory-related errors: you cannot manage what you don’t measure. You manage what you know and measure , 2017, Diagnosis.

[12]  Mario Plebani,et al.  Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” , 2017, Clinical chemistry and laboratory medicine.

[13]  G. Dimeski,et al.  Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube , 2017, Clinical chemistry and laboratory medicine.

[14]  G. Lippi,et al.  Impact of experimental hypercalcemia on routine haemostasis testing , 2017, PloS one.

[15]  D. Mitra,et al.  The economic impact of poor sample quality in clinical chemistry laboratories: results from a global survey , 2017, Annals of clinical biochemistry.

[16]  A. Šimundić,et al.  Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) , 2017, Clinical chemistry and laboratory medicine.

[17]  M. Nybo,et al.  Continuous quality control of the blood sampling procedure using a structured observation scheme , 2016, Biochemia medica.

[18]  Standardizing in vitro diagnostics tasks in clinical trials: a call for action. , 2016, Annals of translational medicine.

[19]  G. Lippi,et al.  Building a bridge to safe diagnosis in health care. The role of the clinical laboratory , 2016, Clinical chemistry and laboratory medicine.

[20]  C. Schmotzer,et al.  Validation of hemolysis index thresholds optimizes detection of clinically significant hemolysis. , 2015, American journal of clinical pathology.

[21]  G. Lippi,et al.  A case of factitious hyponatremia and hypokalemia due to the presence of fibrin gel in serum , 2015, Diagnosis.

[22]  A. Šimundić,et al.  Colour coding for blood collection tube closures – a call for harmonisation , 2015, Clinical chemistry and laboratory medicine.

[23]  Mario Plebani,et al.  Diagnostic Errors and Laboratory Medicine – Causes and Strategies , 2015, EJIFCC.

[24]  G Lippi,et al.  Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). , 2014, Clinica chimica acta; international journal of clinical chemistry.

[25]  G. Lippi,et al.  Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[26]  A. Remaley,et al.  Interferences from blood collection tube components on clinical chemistry assays , 2014, Biochemia medica.

[27]  A. Šimundić,et al.  Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling , 2013, Biochemia medica.

[28]  J. Asirvatham,et al.  Errors in Potassium Measurement: A Laboratory Perspective for the Clinician , 2013, North American journal of medical sciences.

[29]  G. Lippi,et al.  Blood sample contamination by glucose-containing solutions: effects and identification. , 2013, British journal of biomedical science.

[30]  Nora Nikolac,et al.  Preanalytical quality improvement: in quality we trust , 2013, Clinical chemistry and laboratory medicine.

[31]  A. Šimundić,et al.  Laboratory networking and sample quality: a still relevant issue for patient safety , 2012, Clinical chemistry and laboratory medicine.

[32]  G. Lippi,et al.  Quality Standards for Sample Collection in Coagulation Testing , 2012, Seminars in Thrombosis & Hemostasis.

[33]  A. Šimundić,et al.  Preanalytical phase – a continuous challenge for laboratory professionals , 2012, Biochemia medica.

[34]  Julie A. Hammerling A Review of Medical Errors in Laboratory Diagnostics and Where We Are Today , 2012 .

[35]  G. Lippi,et al.  Incomplete filling of lithium heparin tubes affects the activity of creatine kinase and γ-glutamyltransferase , 2012, British journal of biomedical science.

[36]  G. Lippi,et al.  Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens. , 2011, Biochemia medica.

[37]  Mario Plebani,et al.  Closing the brain-to-brain loop in laboratory testing , 2011, Clinical chemistry and laboratory medicine.

[38]  Mario Plebani,et al.  Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories , 2011, Critical reviews in clinical laboratory sciences.

[39]  J. C. Rutledge,et al.  ORIGINAL ARTICLE: Under‐filled blood collection tubes containing K2EDTA as anticoagulant are acceptable for automated complete blood counts, white blood cell differential, and reticulocyte count , 2010, International journal of laboratory hematology.

[40]  A. Šimundić,et al.  Hemolysis detection and management of hemolyzed specimens , 2010 .

[41]  Giuseppe Lippi,et al.  Risk management in the preanalytical phase of laboratory testing , 2007, Clinical chemistry and laboratory medicine.

[42]  Andrea Mosca,et al.  Recommendations for detection and management of unsuitable samples in clinical laboratories , 2007, Clinical chemistry and laboratory medicine.

[43]  G. Lippi,et al.  The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes , 2007, Clinical chemistry and laboratory medicine.

[44]  R. Marlar,et al.  Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. , 2006, American journal of clinical pathology.

[45]  G. Lippi,et al.  Phlebotomy issues and quality improvement in results of laboratory testing. , 2006, Clinical Laboratory.

[46]  T. Bertsch,et al.  Blood loss from laboratory tests. , 2003, Clinical chemistry.

[47]  McPherson Ra Blood sample volumes: emerging trends in clinical practice and laboratory medicine. , 2001 .

[48]  R. Mcpherson Blood sample volumes: emerging trends in clinical practice and laboratory medicine. , 2001, Clinical leadership & management review : the journal of CLMA.

[49]  R. Marlar,et al.  Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. , 1998, American journal of clinical pathology.